The country is embracing the idea of shifting public money into private universities and firms that produce cutting-edge research. This makes for greater bang for the taxpayer’s buck.
We must trust and support early-stage innovations through “adventure” capital, not just risk-averse venture capital. We also need “patient” capital, as the lead times are long in this sector.
